Annals of Oncology

In this issue:

In this issue
Ann Oncol 7: 759.
[PDF] [Request Permissions]

Contents of the next issue:

Contents of the next issue
Ann Oncol 7: 759.
[PDF] [Request Permissions]

News:

Steven Dickman

What does p53 add to cancer therapy? So far, confusion
Ann Oncol 7: 760-761.
[PDF] [Request Permissions]

German budget cuts: Everyone feels the chill
Ann Oncol 7: 761.
[PDF] [Request Permissions]

Asbestos upheaval in France
Ann Oncol 7: 761-762.
[PDF] [Request Permissions]

Italy: More science, fewer drugs, less oncology
Ann Oncol 7: 762.
[PDF] [Request Permissions]

WHO crashes cancer unit
Ann Oncol 7: 762-763.
[PDF] [Request Permissions]

UK: Suddenly, environment and health are priorities
Ann Oncol 7: 763.
[PDF] [Request Permissions]

Oncology in countries with limited resources: Discussion only?
Ann Oncol 7: 763-764.
[PDF] [Request Permissions]

Awards, appointments
Ann Oncol 7: 764.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 7: 764-765.
[PDF] [Request Permissions]

Book reviews:

Martin F. Fey

Book review
Ann Oncol 7: 766.
[PDF] [Request Permissions]

R. O. Mirimanoff

Book review
Ann Oncol 7: 870.
[PDF] [Request Permissions]

Editorials:

Bruce D. Cheson

Ennui or not ennui, that is the question...
Ann Oncol 7: 767-769.
[PDF] [Request Permissions]

Ian E. Smith

Continuous infusional 5-fluorouracil in breast cancer or the revival of an old drug?
Ann Oncol 7: 771-772.
[PDF] [Request Permissions]

Review:

G. C. Jayson and A. Howell

Carcinomatous meningitis in solid tumours
Ann Oncol 7: 773-786.
[Abstract] [PDF] [Request Permissions]

Commentary:

E. Zucca and E. Roggero

Biology and treatment of MALT lymphoma: The state-of-the-art in 1996
Ann Oncol 7: 787-792.
[PDF] [Request Permissions]

Rapid Publications:

D. C. Betticher, E. Zucca, A. von Rohr, T. Egger, J. A. Radford, A. Ambrosetti, K. Bürki, B. Rufener, S. F. Hsu Schmitz, and T. Cerny

2-Chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III–IV non-Hodgkin's lymphoma
Ann Oncol 7: 793-799.
[PDF] [Request Permissions]

T. Colombo, O. Gonzalez Paz, M. Zucchetti, M. Maneo, C. Sessa, A. Goldhirsch, and M. D'Incalci

Paclitaxel induces significant changes in epidoxorubicin distribution in mice
Ann Oncol 7: 801-805.
[Abstract] [PDF] [Request Permissions]

Original articles:

S. Regazzoni, G. Pesce, G. Marini, F. Cavalli, and A. Goldhirsch

Low-dose continuous intravenous infusion of 5-fluorouracil for metastatic breast cancer
Ann Oncol 7: 807-813.
[Abstract] [PDF] [Request Permissions]

K. Furuse, M. Fukuoka, M. Kuba, S. Yamori, Y. Nakai, S. Negoro, N. Katagami, Y. Takada, E. Kinuwaki, M. Kawahara, K. Kubota, A. Sakuma, H. Niitani, and for the Japan Vinorelbine Lung Cancer Cooperative Study Group

Randomized study of vinorelbine (VRB) versus vindesine (VDS) in previously untreated stage IIIB or IV non-small-cell lung cancer (NSCLC)
Ann Oncol 7: 815-820.
[Abstract] [PDF] [Request Permissions]

C. Gridelli, F. Perron, S. Palmeri, M. D'Aprile, F. Cognetti, A. Rossi, V. Gebbia, R. Pepe, E. Veltri, G. Airoma, A. Russo, P. Incoronato, A. F. Scinto, G. Palazzolo, M. Natali, V. Leonardi, C. Gallo, S. De Placido, A. R. Bianco, and on behalf of the ‘Gruppo Oncologico Centro-Sud-Isole’ (G.O.C.S.I.)

Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial
Ann Oncol 7: 821-826.
[Abstract] [PDF] [Request Permissions]

S. S. Legha, S. Ring, A. Bedikian, C. Plager, O. Eton, A. C. Buzaid, and N. Papadopoulos

Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-
Ann Oncol 7: 827-835.
[Abstract] [PDF] [Request Permissions]

J. P. Armand, Y. M. Extra, G. Catimel, D. Abigerges, M. Marty, and M. Clavel

Rationale for the dosage and schedule of CPT-11 (irinotecan) selected for phase II studies, as determined by European phase I studies
Ann Oncol 7: 837-842.
[Abstract] [PDF] [Request Permissions]

L. Y. Dirix, P. B. Vermeulen, G. Hubens, I. Benoy, M. Martin, C. De Pooter, and A. T. Van Oosterom

Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer
Ann Oncol 7: 843-848.
[Abstract] [PDF] [Request Permissions]

Clinical case:

C. Ottensmeier and G. Mead

Histological transformation of indolent (follicular) lymphoma
Ann Oncol 7: 849-853.
[PDF] [Request Permissions]

Short reports:

E. Bruera, R. L. Fainsinger, T. Schoeller, and C. Ripamonti

Rapid discontinuation of hypnotics in terminal cancer patients: A prospective study
Ann Oncol 7: 855-856.
[Abstract] [PDF] [Request Permissions]

A. Michelotti, A. Gennari, B. Salvadori, A. Tognoni, C. Tibaldi, E. Baldini, and P. F. Conte

Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: A phase II study
Ann Oncol 7: 857-860.
[Abstract] [PDF] [Request Permissions]

A. Lissoni, G. Zanetta, G. Losa, A. Gabriele, G. Parma, and C. Mangioni

Phase II study of paclitaxel as salvage treatment in advanced endometrial cancer
Ann Oncol 7: 861-863.
[Abstract] [PDF] [Request Permissions]

G. Bacci, P. Picci, S. Ferrari, M. Mercuri, A. Briccoli, D. Donati, M. Manfrini, A. Zanoni, C. Forni, and M. Campanacci

Synchronous multifocal osteosarcoma: Results in twelve patients treated with neoadjuvant chemotherapy and simultaneous resection of all involved bones
Ann Oncol 7: 864-866.
[Abstract] [PDF] [Request Permissions]

J. Verweij, P. H. M de Mulder, A. de Graeff, J. B. Vermorken, J. Wildier, J. Kerger, J. Schornagel, F. Cognetti, A. Kirkpatrick, T. Sahmoud, and J. L. Lefebvre

Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck
Ann Oncol 7: 867-869.
[Abstract] [PDF] [Request Permissions]

Letters:

S. Fetscher, A. Kiani, L. Kanz, W. Brugger, W. Lange, and R. Mertelsmann

Neo-adjuvant high-dose chemotherapy with autologous peripheral blood stem cell transplantation for inoperable relapse of nuchal liposarcoma resistant to standard-dose chemotherapy
Ann Oncol 7: 871.
[PDF] [Request Permissions]

L. Van Hoe, E. Van Cutsem, I. Vergote, G. Marchal, and A. L. Baert

Reporting on the results of cancer treatment in patients with metastatic liver disease: Proposal of symmetric size-dependent CT-criteria for response
Ann Oncol 7: 871-872.
[PDF] [Request Permissions]

Advertisements in this issue:

Bristol-Meyers Squibb
Ann Oncol 7: 873.
[PDF] [Request Permissions]

Pharmacia & Upjohn
Ann Oncol 7: 873.
[PDF] [Request Permissions]

Kluwer Academic Publishers
Ann Oncol 7: 873.
[PDF] [Request Permissions]

Rhsne-Poulenc Rorer (limited circulation)
Ann Oncol 7: 874.
[PDF] [Request Permissions]

Eli Lilly
Ann Oncol 7: 874.
[PDF] [Request Permissions]

Classified advertisements from ESMO members and meeting announcements
Ann Oncol 7: 874.
[PDF] [Request Permissions]

ESMO applications for membership
Ann Oncol 7: 875.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.